Fewer studies have been carried out with DPP-4 inhibitors
But how long should you expect this side effect to last
This means a demand for insulin (for the rest of their life), insulin pumps and blood glucose monitoring devices/software
They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
Recommended sites include upper arm, shoulder, or lower back
What works optimally for one researcher may require adjustment for another